Paulson & Co. Inc.
- SEC CIK
- 0001035674
- Latest filing
- Aug 14, 2026
HZNP holding history
Horizon Therapeutics Public Ltd Co in every 13F filed by Paulson & Co. Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −2,103,046−100.0% | Sold out | Holders |
| Q3 2023 | 2,103,046 | $243.3M | 21.8% | +1,603,046+320.6% | Added | Holders |
| Q2 2023 | 500,000 | $51.4M | 5.0% | −500,000−50.0% | Reduced | Holders |
| Q1 2023 | 1,000,000 | $109.1M | 9.1% | −500,000−33.3% | Reduced | Holders |
| Q4 2022 | 1,500,000 | $170.7M | 15.4% | −4,600,000−75.4% | Reduced | Holders |
| Q3 2022 | 6,100,000 | $377.5M | 27.6% | −99,000−1.6% | Reduced | Holders |
| Q2 2022 | 6,199,000 | $494.4M | 24.4% | +585,000+10.4% | Added | Holders |
| Q1 2022 | 5,614,000 | $590.6M | 18.2% | −386,000−6.4% | Reduced | Holders |
| Q4 2021 | 6,000,000 | $646.6M | 19.9% | −169,296−2.7% | Reduced | Holders |
| Q3 2021 | 6,169,296 | $675.8M | 19.3% | −1,822,144−22.8% | Reduced | Holders |
| Q2 2021 | 7,991,440 | $748.3M | 17.9% | 00.0% | Unchanged | Holders |
| Q1 2021 | 7,991,440 | $735.5M | 16.9% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.